350 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA
Announces Positive Results from ACACIA-HCM
Other Events
Reports Second Quarter 2026 Financial Results and Provides Business Update
Election of Three Class I Directors at Annual Meeting on May 27, 2026
Cytokinetics Enters Underwriting Agreement for $760.2 Million Offering
Investor Presentation
Reports First Quarter 2026 Financial Results and Provides Business Update
Annual Report to Security Holders
Q2
Q1
FY 2024
Q3
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Submission Upload
Correspondence